Mariam Khalil

Regulated Expansion and Survival of Chimeric Antigen Receptor-Modified T Cells Using Small Molecule-Dependent Inducible MyD88/CD40.

Wei-Chun Chang, J. Bayle, K. Slawin, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer.

Chung-Che Chang, Stephen Gottschalk, Adrian P Gee, 2007, Blood.

Constitutively active MyD88/CD40 costimulation enhances expansion and efficacy of chimeric antigen receptor T cells targeting hematological malignancies

Wei-Chun Chang, J. Bayle, M. Brandt, 2019, Leukemia.

Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes.

P. Hanley, C. Cruz, Hao Liu, 2009, Blood.

Streamlined production of genetically modified T cells with activation, transduction and expansion in closed-system G-Rex bioreactors.

A. Foster, Mariam Khalil, C. Gagliardi, 2019, Cytotherapy.

Antitumor Activity of EBV-specific T Lymphocytes Transduced With a Dominant Negative TGF-β Receptor

H. Heslop, C. Rooney, C. Bollard, 2008, Journal of immunotherapy.

Identification of Hexon-Specific CD4 and CD8 T-Cell Epitopes for Vaccine and Immunotherapy

Malcolm K. Brenner, Helen E. Heslop, Cliona M. Rooney, 2007, Journal of Virology.